Rosalind Franklin University of Medicine & Science
Rosalind Franklin University (RFU) is dedicated to advancing healthcare education and research through interprofessionalism and innovative practices. Named after Dr. Rosalind Franklin, the university fosters a collaborative environment for students and faculty to improve health outcomes and community wellness.
Industries
N/A
Nr. of Employees
small (1-50)
Rosalind Franklin University of Medicine & Science
3333 Green Bay Road, North Chicago, IL 60064
Patents
Combination serotonin specific reuptake inhibitor and serotonin 1A receptor partial agonist for reducing L-DOPA-induced dyskinesia
US-12285426-B2
View Details
Combination serotonin specific reuptake inhibitor and serotonin 1A receptor partial agonist for reducing L-DOPA-induced dyskinesia
US-12285426-B2
View DetailsProducts
Web-based clinical decision-making simulation case
Interactive virtual patient case delivered via web/app to teach clinical recognition and management scenarios, with integrated history-taking, test ordering, and feedback loops for iterative learner improvement.
IND-enabling preclinical research project (example)
Preclinical in vitro and in vivo studies conducted to generate efficacy and safety data supporting regulatory designations and IND submissions for therapeutic development.
Institutional patent portfolio and technology-transfer activities
Aggregate holdings and active patent filings derived from university research, used to protect discoveries and enable licensing and commercialization.
Wet-lab facility expansion project
Laboratory buildout project to add rentable wet-lab space within the innovation and research park to accommodate bioscience-industry tenants and translational research activities.
Web-based clinical decision-making simulation case
Interactive virtual patient case delivered via web/app to teach clinical recognition and management scenarios, with integrated history-taking, test ordering, and feedback loops for iterative learner improvement.
IND-enabling preclinical research project (example)
Preclinical in vitro and in vivo studies conducted to generate efficacy and safety data supporting regulatory designations and IND submissions for therapeutic development.
Institutional patent portfolio and technology-transfer activities
Aggregate holdings and active patent filings derived from university research, used to protect discoveries and enable licensing and commercialization.
Wet-lab facility expansion project
Laboratory buildout project to add rentable wet-lab space within the innovation and research park to accommodate bioscience-industry tenants and translational research activities.
Services
Student-led clinic providing primary care and allied health services, with expanded specialty clinics (ophthalmology, dermatology, pain care, pelvic health), serving uninsured and underserved patients while functioning as an interprofessional training site.
Mobile health service delivery using a mobile health vehicle and vehicle fleet to provide vaccinations, point-of-care infectious disease testing, and outreach services to patients unable to access clinic-based care.
Provision of rentable wet-lab space, research park infrastructure, mentorship, industry partnership facilitation, and commercialization assistance for early-stage biomedical companies and academic spinouts; includes internship and fellowship placements for students.
Design and delivery of simulation curricula and virtual patient cases for clinical reasoning practice, available for on-site instruction and remote web/app deployment.
Continuous library access, electronic resource subscriptions, literature searching, systematic review assistance, and librarian consultation to support education and research.
Student-led clinic providing primary care and allied health services, with expanded specialty clinics (ophthalmology, dermatology, pain care, pelvic health), serving uninsured and underserved patients while functioning as an interprofessional training site.
Mobile health service delivery using a mobile health vehicle and vehicle fleet to provide vaccinations, point-of-care infectious disease testing, and outreach services to patients unable to access clinic-based care.
Provision of rentable wet-lab space, research park infrastructure, mentorship, industry partnership facilitation, and commercialization assistance for early-stage biomedical companies and academic spinouts; includes internship and fellowship placements for students.
Design and delivery of simulation curricula and virtual patient cases for clinical reasoning practice, available for on-site instruction and remote web/app deployment.
Continuous library access, electronic resource subscriptions, literature searching, systematic review assistance, and librarian consultation to support education and research.
Expertise Areas
- Interprofessional clinical education
- Simulation-based healthcare education
- Community health delivery and mobile outreach
- Translational and IND-enabling preclinical research
Key Technologies
- Web- and app-based virtual patient simulation
- Mannequin-based and standardized-patient simulation
- Point-of-care diagnostic testing
- Handheld/point-of-care ultrasound
News & Updates
All Day
December 17, 2024 — 4:30 pm - 6:30 pm
RFU has launched a campaign to help raise donations for free healthcare services in the local community, running until December 16, 2024.
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has been awarded Orphan Drug designation by the FDA for its oncolytic virus-based therapy to treat malignant glioma.
RFU has launched a campaign to help raise donations for free healthcare services in the local community.
Dr. Erin Howe has been awarded a $100,000 grant from the Mary Kay Ash Foundation to study the immune recognition of brain cancer metastases.
All Day
December 17, 2024 — 4:30 pm - 6:30 pm
RFU has launched a campaign to help raise donations for free healthcare services in the local community, running until December 16, 2024.
U.P. Oncolytics, a company in Rosalind Franklin University’s Helix 51 biomedical incubator, has been awarded Orphan Drug designation by the FDA for its oncolytic virus-based therapy to treat malignant glioma.
RFU has launched a campaign to help raise donations for free healthcare services in the local community.
Dr. Erin Howe has been awarded a $100,000 grant from the Mary Kay Ash Foundation to study the immune recognition of brain cancer metastases.